Okeoma Ogo Chukwu, NP in Decatur, GA - Medicare Nurse Practitioner

Okeoma Ogo Chukwu, NP is a medicare enrolled "Nurse Practitioner - Family" in Decatur, Georgia. She graduated from nursing school in 2016 and has 8 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Advantage Behavioral Health Systems and her current practice location is 445 Winn Way, Decatur, Georgia. You can reach out to her office (for appointments etc.) via phone at (678) 949-0969.

Okeoma Ogo Chukwu is licensed to practice in Georgia (license number RN259992) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1043716137.

Contact Information

	Okeoma Ogo Chukwu, NP
	445 Winn Way, Decatur, GA 30030-1707
	(678) 949-0969
	Not Available

Provider's Profile

Full Name	Okeoma Ogo Chukwu
Gender	Female
Speciality	Nurse Practitioner
Experience	8 Years
Location	445 Winn Way, Decatur, Georgia
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Okeoma Ogo Chukwu graduated from nursing school in 2016

NPI Data:

NPI Number: 1043716137
Provider Enumeration Date: 04/05/2018
Last Update Date: 04/05/2018

Medicare PECOS Information:

PECOS PAC ID: 8224377452
Enrollment ID: I20190305001761

Medical Identifiers

Medical identifiers for Okeoma Ogo Chukwu such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043716137	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363LF0000X	Nurse Practitioner - Family	RN259992 (Georgia)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Piedmont Athens Regional Medical Center	Athens, GA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Advantage Behavioral Health Systems	1052200599	21

News Archive

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.

Coventry's Fitch ratings unaffected by Louisiana Court of Appeals' adverse ruling

Fitch Ratings commented today that its ratings on Coventry Health Care, Inc. (Coventry) are unaffected by the company's announcement this morning that it will take a $278 million charge against second-quarter earnings related to an adverse ruling by the Third Circuit Court of Appeals in the state of Louisiana.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Okeoma Ogo Chukwu allows following entities to bill medicare on her behalf.

Entity Name	Advantage Behavioral Health Systems
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1942270558 PECOS PAC ID: 1052200599 Enrollment ID: O20040312000946

News Archive

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Coventry's Fitch ratings unaffected by Louisiana Court of Appeals' adverse ruling

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Okeoma Ogo Chukwu is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Okeoma Ogo Chukwu, NP 3202 Hunter Ridge Ln, Peachtree Corners, GA 30092-3746 Ph: (678) 949-0969	Okeoma Ogo Chukwu, NP 445 Winn Way, Decatur, GA 30030-1707 Ph: (678) 949-0969

News Archive

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Coventry's Fitch ratings unaffected by Louisiana Court of Appeals' adverse ruling

Nurse Practitioner Nurses in Decatur, GA

Antoinette Denise Gamble, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd., Decatur, GA 30033 Phone: 404-321-6111
Sophia P Georges, AGNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1039 Highland Lake Cir, Decatur, GA 30033 Phone: 513-348-2926
Tammy Vardeman Aguilar, RN, NNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 101 W Ponce De Leon Ave, Suite #242, Decatur, GA 30030 Phone: 404-778-7622 Fax: 404-778-7645
Abdul Niazi, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 445 Winn Way, Decatur, GA 30030 Phone: 404-294-3745 Fax: 404-294-3710
Vivian S. Hayes, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd # 170c, Decatur, GA 30033 Phone: 404-321-6111 Fax: 404-235-3038
Ms. Martha J Dorsey, ANPRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 404-728-7748 Fax: 404-728-7782
Jessica Willis, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2722 N Decatur Rd, Decatur, GA 30033 Phone: 678-467-7598

Okeoma Ogo Chukwu, NP - Medicare Nurse Practitioner in Decatur, GA

Contact Information

Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Coventry's Fitch ratings unaffected by Louisiana Court of Appeals' adverse ruling

Medicare Reassignments

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Coventry's Fitch ratings unaffected by Louisiana Court of Appeals' adverse ruling

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Coventry's Fitch ratings unaffected by Louisiana Court of Appeals' adverse ruling

Nurse Practitioner Nurses in Decatur, GA